Objective:We used an animal model to study uterine leiomyoma in the context of pregnancy-associated changes in gene expression and to determine how they might modulate tumor growth.
Methods:Spontaneous tumors and normal myometrium were collected from Eker rats and compared with myometrial samples from pregnant animals. A leiomyoma-derived cell line was also used to assess pregnancy-related changes in gene expression and to determine the impact of signaling by the oxytocin receptor.
Results:Eker rat leiomyomas expressed several pregnancy-related genes, including connexin 43, oxytocin receptor (OTR), and cyclooxygenase (COX)-1; however, the tumors did not express COX-2, which is expressed in the parturient myometrium. The leiomyoma-derived cell lines also expressed OTR, which responds to estrogen, binds to oxytocin, and exhibits a calcium flux when stimulated with oxytocin. The OTR signaling mediated by oxytocin inhibited estrogen-stimulated growth of leiomyoma cells.
Conclusions:Leiomyoma cells expressed many genes of the parturient myometrium, including OTRs, but were deficient in COX-2 expression. Signaling via the OTR appears to inhibit estrogen-induced cell proliferation, suggesting that signaling by this receptor might help mediate the protective effect of pregnancy on this disease.
1. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol1997;90(6):967-973.
2.
2. Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril1998;70(3):432-439.
3.
3. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. BMJ1986;293:359-362.
4.
4. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depotmedroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study. Br J Obstet Gynaecol1996;103(9):901-914.
5.
5. Walker CL, Cesen-Cummings K, Houle C, Baird D, Barrett JC, Davis B. Protective effect of pregnancy for the development of uterine leiomyoma. Carcinogenesis2001;22:2049-2052.
6.
6. Cesen-Cummings K, Copland JA, Barrett JC, Walker CL, Davis BJ. Pregnancy, parturition, and prostaglandins: Defining uterine leiomyomas. Environ Health Perspect2000;108(Suppl 5):817-820.
7.
7. Wu WX, Unno N, Ma XH, Nathanielsz PW. Inhibition of prostaglandin production by mimesulide is accompanied by changes in expression of the cassette of uterine labor-related genes in pregnant sheep. Endocrinology1998;137(7):3096-3103.
9. Andersen J, Grine E, Eng CL, et al. Expression of connexin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol1993;169(5):1266-1276.
10.
10. Lee KH, Khan-Dawood FS, Dawood MY. Oxtocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium. Am J Obstet Gynecol1998;179(3 pt 1):620-627.
11.
11. Hunter DS, Hodges LC, Eagon PK et al. Influence of exogenous estrogen receptor ligands on uterine leiomyoma: Evidence from an in vitro/in vivo animal model for uterine fibroids. Environ Health Perspect2000;108(Suppl 5):829-834.
12.
12. Walker CL, Burroughs KD, Davis B, Sowell K, Everitt JI, Fuchs-Young R. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma. J Soc Gynecol Investig2000;7(4):249-256.
13.
13. Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol1995;146(6):1568-1579.
14.
14. Howe SR, Gottardis MM, Everitt JI, Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology1995;136(11):4996-5003.
15.
15. Slater D, Berger L, Newton R, Moore G, Bennett P. The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun1994;198(1):304-308.
16.
16. Dong YL, Gangula PR, Fang L, Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins1996;52(1):13-34.
17.
17. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter W. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry1979;18:5294-5299.
18.
18. Hinko A, Soloff MS. Characterization of oxytocin receptors in rabbit amnion involved in the production of prostaglandin E2. Endocrinology1992;130(6):3440-3450.
19.
19. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem1985;260(6):3440-3450.
20.
20. Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer1997;72(2):340-344.
21.
21. Draeger A, Graf AH, Staudach A, North AJ, Small JV. Smooth muscle differentiation in human myometrium and uterine leiomyoma. Virchows Arch B Cell Pathol Incl Mol Patho1993;64(1):21-27.
22.
22. Nathanielsz PW. Endocrine mechanisms of parturition. Annu rev Physiol1978;40:411-445.
23.
23. Challis JRG, Mitchell BF. Endocrinology of pregnancy and parturition. In: Warshaw JB, ed. The biological basis of reproductive and developmental medicine. New York: Elsevier Biomedical, 1983:85-131.
24.
24. Zuo J, Lei ZM, Rao CV, Pietrantoni M, Cook VD. Differential cyclooxygenase-1 and 2-gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab1994;79(3):894-899.
25.
25. Slater DM, Dennes WJ, Campa JS, Poston L, Bennett PR. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod1999;5(9):880-884.
26.
26. Fang L, Chatterjee S, Dong UL, Gangula PR, Yallampalli C. Immunohistorical localization of constructive and inducible cyclo-oxygenases in rat uterus during the oestrous cycle and pregnancy. Histochem J1998;30(6):383-391.
27.
27. Trifan OC, Smith RM, Thompson BD, and Hla T. Overexpression of cyclooxygenase-2-induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem1999;274(48):34141-34147.
28.
28. Burroughs KD, Fuchs-Young R, Davis B, Walker CL. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod2000;63(5):1322-1330.
29.
29. Fuchs AR, Fuchs F, Husslein P, Soloff MS, Fernstrom MJ. Oxytocin receptors and human parturition: A dual role for oxytocin in the initiation of labor. Science1982;215(4538):1396-1398.
30.
30. Fuchs AR, Periyasamy S, Alexandrova M, Soloff MS. Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: Effects of ovarian steroids. Endocrinology1983;113(2):742-749.
31.
31. Kimura T, Takemura M, Nomura S, et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology1996:137(2):780-785.
32.
32. Adachi S, Oku M. The regulation of oxytocin receptor expression in human myometrial monolayer culture. J Smooth Muscle Res1995;31(4):175-187.
33.
33. Zingg HH, Rozen F, Breton C, et al. Gonadal steroid regulation of oxytocin and oxytocin receptors gene expression. Adv Exp Med Biol1995;395:395-404.
34.
34. Cassoni P, Sapino A, Negro F, Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch1994;425(5):467-472.
35.
35. Cassoni P, Sapino A, Papotti M, Bussolati G. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. Int J Cancer1996;66(6):817-820.
36.
36. Strakova Z, Soloff MS. Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction. Am J Physiol1997;272(5 Part 1):E870-E876.
37.
37. Hoare S, Copland JA, Strakova Z, et al. The proximal portion of the COOH terminus of the oxytocin receptor is required for coupling to g(q), but not g(i). Independent mechanisms for elevating intracellular calcium concentrations from intracellular stores. J Biol Chem1999;274:28682-28689.
38.
38. Soloff MS, Jeng YJ, Copland JA, Strakova Z, Hoare S. Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells. Exp Physiol2000;85(Suppl):51S-58S.
39.
39. Ambrus G, Rao CV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology1994;135:2772-2779.
40.
40. Garfield R, Sims S, Daniel E. Gap junctions: Their presence and necessity in myometrium during parturition. Science1977;198:958-960.
41.
41. Puri CP, Garfield RE. Changes in hormone levels and gap junctions in the rat uterus during pregnancy and parturition. Biol Reprod1982;27:967-975.
42.
42. Risek B, Guthrie S, Kumar N, Gilula NB. Modulation of gap junction transcript and protein expression during pregnancy in the rat. J Cell Biol1990;110:269-282.
43.
43. Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T. Increased expression okf connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen: progesterone ratio. Endocrinology1993;132:2380-2386.
44.
44. Geimonen E, Boylston E, Royek A, Andersen J. Elevated ocnnexin-43 expression in term human myometrium correlates with elevated c-Jun expression and is independent of myometrial estrogen receptors. J Clin Endocrinol Metab1998;83:1177-1185.
45.
45. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis1990;11:1051-1058.
46.
46. Ruch RJ. The role of gap junctional intercellular communication in neoplasia. Ann Clin Lab Sci1994;24:216-231.
47.
47. Trosko JE, Ruth RJ. Cell-cell communication in carcinogenesis. Front Biosci1998;3:D208-D236.
48.
48. Bruni C. Abnormal cytodifferentiation in leiomyosarcomas induced with injection of nickel subulfide into skeletal muscles of rats. Light and electron microscopic observations. Ann Clin Lab Sci1986;16:118-129.
49.
49. Jone C, Trosko JE, Chang CC. Characterization of a rat liver epithelial cell line to detect inhibitors of metabolic cooperation. In Vitro Cell Dev Biol1987;23:214-220.
